Global Intravenous (IV) Therapy and Vein Access Market 2024-2028

Global Intravenous (IV) Therapy and Vein Access Market 2024-2028

Global Intravenous (IV) Therapy And Vein Access Market 2024-2028

The intravenous (IV) therapy and vein access market is forecasted to grow by USD 6.52 bn during 2023-2028, accelerating at a CAGR of 4.65% during the forecast period. The report on the intravenous (IV) therapy and vein access market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in geriatric population, and increasing demand for parenteral nutrition.

Technavio's intravenous (IV) therapy and vein access market is segmented as below:

• By End-user
• Hospitals
• Clinics
• Ambulatory surgical centers
• By Application
• Medication administration
• Blood-based products
• Nutrition and buffer solution
• Volume expander
• By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advancements in IV solutions as one of the prime reasons driving the intravenous (IV) therapy and vein access market growth during the next few years. Also, increase in number of approved IV drugs used for therapy and increase in healthcare expenditure and healthcare insurance will lead to sizable demand in the market.

The report on the intravenous (IV) therapy and vein access market covers the following areas:

• Intravenous (IV) therapy and vein access market sizing
• Intravenous (IV) therapy and vein access market forecast
• Intravenous (IV) therapy and vein access market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intravenous (IV) therapy and vein access market vendors that include AngioDynamics Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Cardinal Health Inc., Fresenius SE and Co. KGaA, ICU Medical Inc., IRadimed Corp., Medtronic PLC, Poly Medicure Ltd., Smith and Nephew PLC, Tekni Plex Inc., Teleflex Inc., Terumo Corp., and Vygon SAS. Also, the intravenous (IV) therapy and vein access market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.